Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
PfizerPFE |
$440,000 |
 |
Johnson & JohnsonJNJ |
-$120M |
 |
Mind Medicine (MindMed)MNMD |
-$86M |
 |
ModernaMRNA |
-$37.4B |
 |
AbbVieABBV |
-$792M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Weiss Amir | Dec 16, 2025 | Sell | 12,300 | $30.2036 | $370,000 |
| MIGNONE ROBERTO | Dec 16, 2025 | Sell | 77,400 | $30.2409 | $2.3M |
| Daniell Richard | Dec 9, 2025 | Sell | 115,468 | $28.6757 | $3.3M |
| Sabag Mark | Dec 9, 2025 | Sell | 98,168 | $28.7026 | $2.8M |
| Sabag Mark | Dec 9, 2025 | Sell | 118,724 | $28.748 | $3.4M |
| MIGNONE ROBERTO | Nov 26, 2025 | Sell | 50,000 | $26.0301 | $1.3M |
| Fox Christine | Nov 20, 2025 | Sell | 28,229 | $24.7803 | $700,000 |
| Fox Christine | Nov 14, 2025 | Sell | 30,000 | $25.1107 | $750,000 |
| MIGNONE ROBERTO | Nov 6, 2025 | Sell | 200,000 | $24.1094 | $4.8M |
| Weiss Amir | Nov 6, 2025 | Sell | 12,300 | $24.4361 | $300,000 |
| McAvoy David R. | Sep 5, 2025 | Buy | 1,113 | $18.8572 | $21,000 |
| Jover Placid | Aug 1, 2025 | Sell | 6,053 | $15.1575 | $92,000 |
| Hughes Eric A | Aug 1, 2025 | Sell | 52,742 | $15.1575 | $800,000 |
| Kalif Eliyahu Sharon | Jun 12, 2025 | Sell | 55,775 | $17.0769 | $950,000 |
| Shields Matthew | Jun 3, 2025 | Sell | 6,206 | $17.0203 | $110,000 |
| Sabag Mark | May 8, 2025 | Sell | 337,915 | $18.0439 | $6.1M |
| Daniell Richard | Mar 5, 2025 | Sell | 48,385 | $15.901 | $770,000 |
| Daniell Richard | Mar 5, 2025 | Sell | 22,576 | $15.9139 | $360,000 |
| Fox Christine | Mar 5, 2025 | Sell | 2,147 | $15.9132 | $34,000 |
| McAvoy David R. | Mar 5, 2025 | Sell | 1,677 | $15.9132 | $27,000 |
| Hughes Eric A | Mar 5, 2025 | Sell | 8,077 | $15.9132 | $130,000 |
| Daniell Richard | Mar 5, 2025 | Sell | 7,108 | $15.9132 | $110,000 |
| Francis Richard D | Mar 5, 2025 | Sell | 8,259 | $15.9132 | $130,000 |
| Daniell Richard | Mar 5, 2025 | Sell | 30,015 | $15.9132 | $480,000 |
| Daniell Richard | Mar 5, 2025 | Sell | 11,641 | $15.9132 | $190,000 |
| Daniell Richard | Mar 4, 2025 | Sell | 13,353 | $15.7346 | $210,000 |
| Francis Richard D | Mar 4, 2025 | Sell | 6,450 | $15.5576 | $100,000 |
| Hughes Eric A | Mar 4, 2025 | Sell | 5,174 | $15.5576 | $80,000 |
| Francis Richard D | Mar 4, 2025 | Sell | 15,514 | $15.7346 | $240,000 |
| Daniell Richard | Mar 4, 2025 | Sell | 21,870 | $15.7346 | $340,000 |
| Daniell Richard | Mar 4, 2025 | Sell | 56,385 | $15.7346 | $890,000 |
| Hughes Eric A | Mar 4, 2025 | Sell | 15,174 | $15.7346 | $240,000 |
| Daniell Richard | Mar 4, 2025 | Sell | 12,936 | $15.5576 | $200,000 |
| McAvoy David R. | Mar 4, 2025 | Sell | 3,150 | $15.7346 | $50,000 |
| Fox Christine | Mar 4, 2025 | Sell | 4,034 | $15.7346 | $63,000 |
| Daniell Richard | Mar 3, 2025 | Sell | 49,314 | $16.1855 | $800,000 |
| Hughes Eric A | Mar 3, 2025 | Sell | 19,726 | $16.1855 | $320,000 |
| Francis Richard D | Mar 3, 2025 | Sell | 24,892 | $16.1855 | $400,000 |
| Kalif Eliyahu Sharon | Feb 28, 2025 | Sell | 55,750 | $16.2056 | $900,000 |
| Francis Richard D | Feb 18, 2025 | Sell | 75,506 | $16.9478 | $1.3M |
| Sabag Mark | Feb 12, 2025 | Sell | 177,626 | $16.2508 | $2.9M |
| MIGNONE ROBERTO | Dec 20, 2024 | Sell | 286,000 | $22.0071 | $6.3M |
| Fox Christine | Nov 20, 2024 | Sell | 19,388 | $16.8705 | $330,000 |
| Daniell Richard | Aug 12, 2024 | Sell | 98,943 | $17.2973 | $1.7M |
| Grant Angus | Aug 9, 2024 | Sell | 4,065 | $17.28 | $70,000 |
| Hughes Eric A | Aug 9, 2024 | Sell | 45,060 | $17.3762 | $780,000 |
| Hughes Eric A | Aug 1, 2024 | Sell | 24,537 | $17.2507 | $420,000 |
| MIGNONE ROBERTO | Jun 18, 2024 | Sell | 519,000 | $17.03 | $8.8M |
| Weiss Amir | May 16, 2024 | Sell | 12,635 | $16.6503 | $210,000 |
| Weiss Amir | May 15, 2024 | Sell | 15,500 | $16.8011 | $260,000 |
| Conway Vikki L | May 13, 2024 | Sell | 15,219 | $16.7427 | $250,000 |
| Kalif Eliyahu Sharon | Mar 6, 2024 | Sell | 77,550 | $13.5154 | $1M |
| Daniell Richard | Mar 5, 2024 | Sell | 26,053 | $13.5154 | $350,000 |
| Daniell Richard | Mar 5, 2024 | Sell | 22,576 | $13.5154 | $310,000 |
| Conway Vikki L | Mar 5, 2024 | Sell | 1,427 | $13.5154 | $19,000 |
| Sabag Mark | Mar 5, 2024 | Sell | 100,000 | $13.5209 | $1.4M |
| Hughes Eric A | Mar 4, 2024 | Sell | 8,045 | $13.3373 | $110,000 |
| Daniell Richard | Mar 4, 2024 | Sell | 33,512 | $13.3373 | $450,000 |
| Daniell Richard | Mar 4, 2024 | Sell | 62,250 | $13.3373 | $830,000 |
| Francis Richard D | Mar 4, 2024 | Sell | 31,061 | $13.3373 | $410,000 |
| Conway Vikki L | Mar 4, 2024 | Sell | 2,042 | $13.3733 | $27,000 |
| Conway Vikki L | Mar 4, 2024 | Sell | 1,490 | $13.3733 | $20,000 |
| Drape Eric | Feb 28, 2024 | Sell | 9,815 | $13.116 | $130,000 |
| Daniell Richard | Feb 28, 2024 | Sell | 20,599 | $13.116 | $270,000 |
| Conway Vikki L | Feb 28, 2024 | Sell | 1,366 | $13.116 | $18,000 |
| Drape Eric | Feb 16, 2024 | Sell | 173,261 | $13.0549 | $2.3M |
| Francis Richard D | Feb 15, 2024 | Sell | 74,530 | $13.1514 | $980,000 |
| Weiss Amir | Feb 1, 2024 | Sell | 31,766 | $12.3703 | $390,000 |
FAQ - Insider Transactions
The most recent insider transaction for Teva Pharmaceutical was conducted by Weiss Amir, who sold 12,300 shares on December 16, 2025 at a price of $30.20 per share.
McAvoy David R. has bought the most TEVA stock in the last 2 years, with a total value of $21,000.
MIGNONE ROBERTO has sold the most TEVA stock in the last 2 years, with a total value of $24M.
The total value of insider transactions for Teva Pharmaceutical in the last 2 years is negative, amounting to -$68M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for Teva Pharmaceutical have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
